The process of giving a beam-emitting iodine atom to the patient, commonly known as atomic therapy, has been giving hope to many cancer treatments in recent years. Explaining that targeted molecules are marked in nuclear medicine laboratories and injected intravenously to a patient, Nuclear Medicine Specialist Nalan Alan Selçuk sttated that “Thyroid cancer patients have a recovery rate over 90 percent with a single dose of iodine. This process also contributes to the treatment of neuroendocrine tumour at a rate of 82 percent”.

Pointing out that cancer is a health problem with an increasing incidence, Yeditepe University Hospital Department of Nuclear Medicine,  Assoc. Prof. Nalan Alan Selçuk shared important information about 'nuclear medicine treatment methods' and their success rates. Stating that atomic therapy has been used especially in the treatment of thyroid cancer since the early 1940s, Assoc. Prof. Dr. Nalan Alan Selçuk said, “For the last 20 years, we have started to use this treatment extensively in prostate cancer and tumors originating from neurons and nerve cells originating from the intestine and stomach, which we call neuroendocrine tumors, as well as liver tumors”.


“These molecules are targeted and find the organ to go to”

Stating that radioactive substances are sent to the body in doses that will not harm the person in atomic treatment, Assoc. Prof. Nalan Alan Selçuk said, “One of the treatments we have recently called targeted therapies or smart therapies is atom therapy. These molecules, which are targeted and able to find the organ they will go to, are marked in the nuclear medicine laboratory and given to the patient, usually intravenously. Molecules find the target and enter the cell. Here, they only destroy the tumor tissue. By giving less radiation to other areas of the body, a safer, selective treatment method is provided”.

“First Step is Atomic Therapy in a Large Thyroid Cancer”

Providing information about the types of cancer in which atomic therapy is applied, Assoc. Prof. Nalan Alan Selçuk stated the following: “Features such as the size of the tumor, its pathological type, and its spread pattern, such as the presence of lymph node spread in the neck, determine whether the patient will receive atomic therapy or not. What we mean by atomic treatment is 'iodine 131' treatment. Generally, over 90 percent of these patients are treated by taking iodine once. Of course, the amount of tissue left after the surgery, the iodine capture capacity of the thyroid gland, and the type of the disease are the factors that increase the success of the treatment. Pancreatic cancer is known among the people as a rapidly growing and deadly type of cancer. The progression of pancreatic cancer is usually rapid and treatment options are more difficult than normal cell types, but if the pancreatic cell type contains neuroendocrine, these diseases can also be treated. After atomic treatment, we get very satisfactory results in this group. We are talking about tumors of neuroendocrine origin of the pancreas. These tumors most commonly metastasize to the liver. Even in such a situation, it is possible for us to have a chance to treat the patient with smart molecules or to increase the patient's quality of life by stopping the progression of the tumor.”

What If it doesn't Respond to Surgery or Chemotherapy?

Explaining that neuroendocrine cancers are a common tumor of many organs of the body, especially stomach, intestine, pancreas, lung and thyroid, Yeditepe University Hospitals Nuclear Medicine Specialist Assoc. Prof. Dr. Selçuk stated the following: “We use atomic therapy in these cancers in advanced patients who do not have a chance for surgery or do not respond to chemotherapy, because patients who come to nuclear medicine are now patients in the 3rd and 4th stages of cancer. They are patients who have lost the opportunity of more traditional methods used in cancer treatment, namely surgery, chemotherapy and radiotherapy. Since these patients have come to us in the last stage, their life expectancy is short. Despite this, our goal is to stop these diseases, prolong the life of people and improve their quality of life. It has been demonstrated by current data that neuroendocrine tumors prevent advanced diseases at a rate of 82 percent and contribute to the treatment. These patients come to us with their hopes lost, and despite this, the rates can be satisfactory”.




Whether you live in Istanbul, across Turkey or around world, specialists at Yeditepe University Healthcare Institutions are available to review your medical records and provide an expert opinion on your diagnosis or treatment plan -without the need for an in- person visit.

Yeditepe University Healthcare Institutions collaborates with digital platforms via tele-medicine, to offer remote second opinions from Yeditepe University Healthcare Institutions in virtually every medical specialty. Having a second opinion can reassure you about a challenging diagnosis, or help you and your doctor plan the most appropriate course of treatment.

To have a medical second opinion, click here and complete the online form or call us on 009 0216 578 4 578

Making an appointmet at Yeditepe University Healthcare Institutions couldn't be easier, wheter you use your private medical insurance, pay for your own treatment ora re funded by third party.

As one of the region's leading independent private hospitals, we offer appointments with World class specialist and experts.

As an international patient, you will be you will be offered comprehensive service in the language of your choice right from your initial enquiry, through your medical treatment and, if necessary, help in liaising with your doctor in your home country upon your return home.

To book an appointment, click here and complete the online form or call us on 009 0216 578 4 578

Plese click here for Frequently Asked Questions regarding Yeditepe University Healthcare Institutions